Skip to content

Clinical trials

Completed Phase 2 Respiratory Syncytial Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Phase 2 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20101
20111
20121
20131
20143
20153
20166
20171
20183
20192
20204
20212
20222
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Alnylam Pharmaceuticals3
Enanta Pharmaceuticals, Inc3
Gilead Sciences3
Alios Biopharma Inc.2
Bavarian Nordic2
Janssen Research & Development, LLC2
MedImmune LLC2
Novavax2
Shanghai Ark Biopharmaceutical Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections40
Virus Diseases2
Infections1
Neoplasms1
Pneumonia1
Premature Birth1
Respiratory Tract Infections1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.